A
Ahmed El-Shater Bosaily
Researcher at University College London
Publications - 16
Citations - 2335
Ahmed El-Shater Bosaily is an academic researcher from University College London. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 7, co-authored 15 publications receiving 1682 citations. Previous affiliations of Ahmed El-Shater Bosaily include University College Hospital & University College London Hospitals NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
Hashim U. Ahmed,Hashim U. Ahmed,Ahmed El-Shater Bosaily,Ahmed El-Shater Bosaily,Louise Brown,Rhian Gabe,Richard Kaplan,Mahesh K.B. Parmar,Yolanda Collaco-Moraes,Katie Ward,Richard Hindley,Alex Freeman,Alex Kirkham,Robert Oldroyd,Chris Parker,Mark Emberton,Mark Emberton +16 more
TL;DR: Using MP-MRI to triage men might allow 27% of patients avoid a primary biopsy and diagnosis of 5% fewer clinically insignificant cancers, as well as reduce unnecessary biopsies by a quarter.
Journal ArticleDOI
Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
Louise Brown,Hashim U. Ahmed,Hashim U. Ahmed,Rita Faria,Ahmed El-Shater Bosaily,Ahmed El-Shater Bosaily,Rhian Gabe,Richard Kaplan,Mahesh K. B. Parmar,Yolanda Collaco-Moraes,Katie Ward,Richard Hindley,Alex Freeman,Alexander Kirkham,Robert Oldroyd,Chris Parker,Simon Bott,Nick Burns-Cox,Tim Dudderidge,Maneesh Ghei,Alastair Henderson,Rajendra Persad,Derek J. Rosario,Iqbal S. Shergill,Mathias Winkler,Marta Soares,Eldon Spackman,Mark Sculpher,Mark Emberton,Mark Emberton +29 more
TL;DR: Multiparametric magnetic resonance imaging used as a triage test might allow men to avoid unnecessary TRUS-guided biopsy and improve diagnostic accuracy, and the cost-effectiveness of a mpMRI-based diagnostic pathway is estimated.
Journal ArticleDOI
What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort.
Joseph M. Norris,Joseph M. Norris,Lina M. Carmona Echeverria,Simon Bott,Louise Brown,Nick Burns-Cox,Tim Dudderidge,Ahmed El-Shater Bosaily,Ahmed El-Shater Bosaily,Eleni Frangou,Alex Freeman,Maneesh Ghei,Alastair Henderson,R. Hindley,R. Hindley,Richard Kaplan,Alex Kirkham,Robert Oldroyd,Chris Parker,Raj Persad,Shonit Punwani,Shonit Punwani,Derek J. Rosario,Iqbal S. Shergill,Vasilis Stavrinides,Mathias Winkler,Mathias Winkler,Hayley C. Whitaker,Hashim U. Ahmed,Hashim U. Ahmed,Mark Emberton,Mark Emberton +31 more
TL;DR: Prostate cancers that are undetected by magnetic resonance imaging (MRI) are smaller and less aggressive than those that are detected, and none of the most aggressive cancers are overlooked by MRI.
Journal ArticleDOI
Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS Study.
Ahmed El-Shater Bosaily,Ahmed El-Shater Bosaily,Elena Frangou,Hashim U. Ahmed,Mark Emberton,Shonit Punwani,Richard Kaplan,Louise Brown,Alex Freeman,Charles Jameson,Richard Hindley,Delia Peppercorn,Andrew Thrower,Mathias Winkler,Tara Barwick,Victoria Stewart,Nick Burns-Cox,Paul Burn,Maneesh Ghei,Jeevan Kumaradevan,Raj Prasad,Janice Ash-Miles,Iqbal S. Shergill,Sanjay K. Agarwal,Derek J. Rosario,Ferekh Salim,Simon Bott,Hywel Evans,Alastair Henderson,Sukanya Ghosh,Tim Dudderidge,J Smart,Ken Tung,Alexander Kirkham +33 more
TL;DR: An intravenous injection of contrast may not be necessary when magnetic resonance imaging is used as a test to rule out significant tumours in the prostate, and contrast adds little when MP-MRI is used to exclude significant prostate cancer.
Journal ArticleDOI
The PROMIS study: A paired-cohort, blinded confirmatory study evaluating the accuracy of multi-parametric MRI and TRUS biopsy in men with an elevated PSA.
Hashim U. Ahmed,Ahmed El-Shater Bosaily,Louise Brown,Richard Kaplan,Yolanda Colaco-Moraes,Katie Ward,Richard Hindley,Alex Freeman,Alex K Kirkham,Robert Oldroyd,Rhian Gabe,Chris Parker,Mark Emberton +12 more
TL;DR: Multi-parametric magnetic resonance imaging as a triage test might allow men to avoid unnecessary transrectal ultrasound-guided (TRUS) prostate biopsy since many men with an elevated PSA do not have clinically significant prostate cancer.